Emergent Biosolutions - 1 Year Dividend Yield History | EBS

Historical dividend payout and yield for Emergent Biosolutions (EBS) since 2018. The current TTM dividend payout for Emergent Biosolutions (EBS) as of February 19, 2019 is $0.00. The current dividend yield for Emergent Biosolutions as of February 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.371B $0.561B
Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining the trust of their customers, employees and shareholders. The foundation of the corporate governance principles and practices are built on their reputation for openness, integrity and accountability. These are the principles that guide Emergent BioSolutions everyday. They have in place policies and practices to ensure that their Company is managed with integrity and in their shareholders' best interests. In addition, they are committed to meeting the requirements of federal and state law and the rules of the New York Stock Exchange.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Bio-Techne Corp (TECH) United States $7.237B 48.76